Prostate Neuroendocrine Neoplasm — Trials

Prostate Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04592237	Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer	active not recruiting	Phase 2	120	M.D. Anderson Cancer CenterOTHER	1	Sep 9, 2026	clinicaltrials
NCT04471974	ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer	active not recruiting	Phase 2	61	Rahul AggarwalOTHER	1	Jul 23, 2026	clinicaltrials
NCT04709276	A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer(CHAMP)	active not recruiting	Phase 2	41	Andrew J. Armstrong, MDOTHER	1	Apr 6, 2026	clinicaltrials
NCT03582475

Data updated 21 days agoSource updated Sep 9, 2026source: clinicaltrials